GovTrack.us

 
Bookmark and Share
H.R. 977:
Genomic Research and Accessibility Act
110th Congress

This is a bill in the U.S. Congress originating in the House of Representatives ("H.R."). A bill must be passed by both the House and Senate and then be signed by the President before it becomes law.

Bill numbers restart from 1 every two years. Each two-year cycle is called a session of Congress. This bill was created in the 110th Congress, in 2007-2008.

The titles of bills are written by the bill's sponsor and are a part of the legislation itself. GovTrack does not editorialize bill summaries.

2007-2008

To amend title 35, United States Code, to prohibit the patenting of human genetic material.

Overview

Sponsor:
Text:
Summary | Full Text
Status:
Occurred: IntroducedFeb 9, 2007
Occurred: Referred to CommitteeView Committee Assignments
Not Yet Occurred: Reported by Committee(did not occur)
Not Yet Occurred: House Vote(did not occur)
Not Yet Occurred: Senate Vote(did not occur)
Not Yet Occurred: Signed by President(did not occur)
This bill never became law. This bill was proposed in a previous session of Congress. Sessions of Congress last two years, and at the end of each session all proposed bills and resolutions that haven't passed are cleared from the books. Members often reintroduce bills that did not come up for debate under a new number in the next session.
Last Action:
Mar 1, 2007: Referred to the Subcommittee on Courts, the Internet, and Intellectual Property.
Related:
See the Related Legislation page for other bills related to this one and a list of subject terms that have been applied to this bill. Sometimes the text of one bill or resolution is incorporated into another, and in those cases the original bill or resolution, as it would appear here, would seem to be abandoned.
Question & Answer
Can you answer any of these questions posed by other users? Think of it as a civic good deed. You can submit a short question too.

Nov 17, 2008 2:58 AM - Michael Crichton wrote about how the U.S. Patent Office's decision to patent genes was a major error that needed to be remedied. Does anyone know whether this bill has been abandoned, or whether its text was incorporated into other legislation? - Answer it!
Dec 26, 2008 8:14 PM - Why is this bill stalled? I believe it attempts to fix an error made by PTO. - Read Answers

Sources of Influence

MAPLight.org reports that the following organizations have taken a stance on this bill:

SupportOppose
College of American Pathologists
American College of Medical Genetics
The Association for Molecular Pathology
Intellectual Property Owners Association

Follow the link to MAPLight.org to see if campaign contributions from employees of these organizations are correlated with how Members of Congress voted on this bill.

Because the U.S. Congress posts most legislative information online one legislative day after events occur, GovTrack is usually one legislative day behind. For more information about where this data comes from, see About GovTrack.us.
To cite this information, click a citation format for a suggestion: APA | MLA | Wikipedia Template.